Literature DB >> 26229138

Trimethylamine N-Oxide as a Novel Therapeutic Target in CKD.

W H Wilson Tang1.   

Abstract

Entities:  

Keywords:  CKD; coronary artery disease; trimethylamine N-oxide

Mesh：

Substances：

Year:  2015        PMID： 26229138      PMCID： PMC4696591          DOI： 10.1681/ASN.2015050576

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  22 in total

1.  Citrate, acetate and renal medullary osmolyte excretion in urine as predictor of renal changes after cold ischaemia and transplantation.

Authors:  T Hauet; H Baumert; H Gibelin; C Godart; M Carretier; M Eugene
Journal:  Clin Chem Lab Med       Date:  2000-11       Impact factor: 3.694

2.  Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.

Authors:  W H Wilson Tang; Zeneng Wang; Kevin Shrestha; Allen G Borowski; Yuping Wu; Richard W Troughton; Allan L Klein; Stanley L Hazen
Journal:  J Card Fail       Date:  2014-11-20       Impact factor: 5.712

3.  Nuclear magnetic resonance studies of blood plasma and urine from subjects with chronic renal failure: identification of trimethylamine-N-oxide.

Authors:  J D Bell; J A Lee; H A Lee; P J Sadler; D R Wilkie; R H Woodham
Journal:  Biochim Biophys Acta       Date:  1991-02-22

4.  Renal N-oxidation of trimethylamine in the chicken during tubular excretion.

Authors:  M Acara; S Camiolo; B Rennick
Journal:  Drug Metab Dispos       Date:  1977 Jan-Feb       Impact factor: 3.922

5.  Transmission of atherosclerosis susceptibility with gut microbial transplantation.

Authors:  Jill C Gregory; Jennifer A Buffa; Elin Org; Zeneng Wang; Bruce S Levison; Weifei Zhu; Matthew A Wagner; Brian J Bennett; Lin Li; Joseph A DiDonato; Aldons J Lusis; Stanley L Hazen
Journal:  J Biol Chem       Date:  2014-12-30       Impact factor: 5.157

6.  Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.

Authors:  W H Wilson Tang; Zeneng Wang; David J Kennedy; Yuping Wu; Jennifer A Buffa; Brendan Agatisa-Boyle; Xinmin S Li; Bruce S Levison; Stanley L Hazen
Journal:  Circ Res       Date:  2014-11-05       Impact factor: 17.367

7.  Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.

Authors:  George A Kaysen; Kirsten L Johansen; Glenn M Chertow; Lorien S Dalrymple; John Kornak; Barbara Grimes; Tjien Dwyer; Alexander W Chassy; Oliver Fiehn
Journal:  J Ren Nutr       Date:  2015-03-19       Impact factor: 3.655

8.  Trimethylamine-N-oxide: a carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin II in rats.

Authors:  Marcin Ufnal; Radoslaw Jazwiec; Michal Dadlez; Adrian Drapala; Mariusz Sikora; Janusz Skrzypecki
Journal:  Can J Cardiol       Date:  2014-09-21       Impact factor: 5.223

9.  Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation.

Authors:  Brian J Bennett; Thomas Q de Aguiar Vallim; Zeneng Wang; Diana M Shih; Yonghong Meng; Jill Gregory; Hooman Allayee; Richard Lee; Mark Graham; Rosanne Crooke; Peter A Edwards; Stanley L Hazen; Aldons J Lusis
Journal:  Cell Metab       Date:  2013-01-08       Impact factor: 27.287

10.  Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden.

Authors:  Jason R Stubbs; John A House; A Jacob Ocque; Shiqin Zhang; Cassandra Johnson; Cassandra Kimber; Kyle Schmidt; Aditi Gupta; James B Wetmore; Thomas D Nolin; John A Spertus; Alan S Yu
Journal:  J Am Soc Nephrol       Date:  2015-07-30       Impact factor: 10.121
View more
  4 in total

1.  Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies.

Authors:  Jiaqian Qi; Tao You; Jing Li; Tingting Pan; Li Xiang; Yue Han; Li Zhu
Journal:  J Cell Mol Med       Date:  2017-08-07       Impact factor: 5.310

2.  Trimethylamine-N-oxide is an independent risk factor for hospitalization events in patients receiving maintenance hemodialysis.

Authors:  Yin Zheng; Zihui Tang; Li You; Yuanhao Wu; Junfeng Liu; Jun Xue
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

3.  Dimethylamine enhances platelet hyperactivity in chronic kidney disease model.

Authors:  Yongning Gao; Jingyu Zhang; Hui Chen; Zhu Wang; Jingjing Hou; Lihua Wang
Journal:  J Bioenerg Biomembr       Date:  2021-07-30       Impact factor: 2.945

Review 4.  Uremic Toxins and Their Relation with Oxidative Stress Induced in Patients with CKD.

Authors:  Anna Pieniazek; Joanna Bernasinska-Slomczewska; Lukasz Gwozdzinski
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.